AI Verdict
KNSA has stronger fundamentals based on our AI analysis.
KNSA vs KMX Fundamental Comparison
| Metric | KNSA | KMX |
|---|---|---|
| Revenue | $677.6M | $19.9B |
| Net Income | $59.0M | $368.0M |
| Net Margin | 8.7% | 1.8% |
| ROE | 10.4% | 6.1% |
| ROA | 7.7% | 1.4% |
| Current Ratio | 3.79x | 1.99x |
| Debt/Equity | 0.00x | 2.74x |
| EPS | $0.75 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KNSA vs KMX: Frequently Asked Questions
Is KNSA or KMX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KNSA has stronger fundamentals. KNSA is rated HOLD (68% confidence) while KMX is rated HOLD (55% confidence). This is not investment advice.
How does KNSA compare to KMX fundamentally?
Kiniksa Pharmaceuticals International, plc has ROE of 10.4% vs CARMAX INC's 6.1%. Net margins are 8.7% vs 1.8% respectively.
Which stock pays higher dividends, KNSA or KMX?
KNSA has a dividend yield of N/A or no dividend while KMX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KNSA or KMX for long term?
For long-term investing, consider that KNSA has HOLD rating with 68% confidence, while KMX has HOLD rating with 55% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KNSA vs KMX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KNSA vs KMX, the AI consensus favors KNSA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.